Xenon Pharmaceuticals Inc. trailing returns
Xenon Pharmaceuticals Inc.'s 10-year return is +15.6% a year (CAGR) (+326.9% cumulative). How Xenon Pharmaceuticals Inc. (XENE) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 22, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-22. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +1.5% | +0.0% | +1.5% | — |
| 5 days | +6.3% | +0.0% | +6.3% | -2.4%Oct 16 |
| 1 month | -6.6% | +0.0% | -6.6% | -14.3%Oct 16 |
| YTD | -18.6% | +0.0% | -18.6% | -52.8%Oct 16 |
| 1 year | -13.5% | +0.0% | -13.5% | -52.8%Oct 2026 |
| 5 years | +3.4% | +0.0% | +3.4%+18.3% | -52.8%Oct 2026 |
| 10 years | +15.6% | +0.0% | +15.6%+326.9% | -77.7%Nov 2017 |
| Since inception (2014) | +11.0% | +0.0% | +11.0%+247.6% | -90.4%Nov 2017 |
Growth of XENE#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+3.4%/year · +18.3%
- 10 years+15.6%/year · +326.9%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-22). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in XENE's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Xenon Pharmaceuticals Inc.'s 10-year return?
- Over the last 10 years, Xenon Pharmaceuticals Inc. (XENE) returned about +15.6% a year annualized (+326.9% cumulative total return).
- What is Xenon Pharmaceuticals Inc.'s return since inception?
- Since 2014, Xenon Pharmaceuticals Inc. (XENE) has compounded at about +11.0% a year — +247.6% in total.